Swiss stocks - Factors to watch on February 6

Morphosys AG

06/02/2024 05:55

ZURICH/BERLIN, Feb 6(Reuters) - Here are some of the
main factors that may affect Swiss stocks on Tuesday:
    
    COMPANY STATEMENTS
    
    UBS GROUP AG  UBSG.S  
    UBS Group on Tuesday reported a loss of $279 million
attributable to shareholders in the fourth quarter, less than
the expected loss of $285 million forecast by analysts in a
company-provided poll. 
    
    NOVARTIS  NOVN.S 
    Drugmaker Novartis said on Monday it will acquire MorphoSys
AG  MORG.DE , a developer of cancer treatments, for 2.7 billion
euros ($2.9 billion), adding a promising rare bone-marrow cancer
treatment candidate to its portfolio.
    
    * Stadler Rail  SRAIL.S  and Saudi Arabia Railways signed
contracts for trains supply and maintenance.
    
    
    ANALYSTS' VIEWS

    ECONOMY
    No major Swiss economic data scheduled.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))